MSACL 2022 : Kuzdzal

MSACL 2022 Industry Workshop Presentation

*This Podium Presentation is occuring in the context of an Industry Workshop that starts at the time below. Its actual start time may be up to 40 minutes later, depending on order of presentation if there are multiple presentations planned by the workshop host.

Workshop Host:Shimadzu
Day:Thursday April 7
Location:De Anza 3 (Track 3)

Do More with Less: Ease the Burden of Staff Shortages while Simultaneously Boosting Lab Productivity with Ultra-Fast Mass Spectrometry
Scott Kuzdzal, Ph.D., Analytical Chemistry
Shimadzu Scientific Instruments

Presenter Bio: Dr. Scott Kuzdzal received a Ph.D. from the University of California at Riverside. He served as a postdoctoral fellow at the Johns Hopkins University School of Medicine, where he co-founded and directed the Johns Hopkins Center for Biomarker Discovery with Dr. Daniel Chan. Dr. Kuzdzal assisted in the completion of the Human Genome Project, working with Celera Genomics. In addition to extensive industrial research experience, Dr. Kuzdzal has a strong medicinal and clinical chemistry background and has directed Toxicology and Therapeutic Drug Monitoring Labs at Johns Hopkins Medical Institutions. He currently serves on the editorial review board of Proteomics. He has published protein and peptide biomarkers for pancreatic cancer (HIPAP1), Alzheimer’s disease and ovarian cancer using a wide variety of separation and detection methods. Scott has lectured at continuing medical education courses at Johns Hopkins Hospital, George Mason University/INOVA Fairfax Hospital and the NIH, as well as conferences worldwide. Scott currently serves as the Vice President of the New Strategy Department at Shimadzu Scientific Instruments. He has created many products and brands, such as Kick Some Mass™, Analytical Intelligence™, MegaTOF™ and the Cannabis Analyzer. Dr. Kuzdzal has over 350 scientific manuscripts, book chapters and presentations. His passion is improving clinical and QC laboratory testing, and development of new, integrated health systems. Publications:


Introduction to Ultra-Fast Mass Spectrometry (UFMS)

Clinical laboratory professionals may feel over-worked and underappreciated as the COVID-19 pandemic has resulted in staff shortages and budget constraints. These shortages and limitations pose problems not only for patient care, but also have negatively impacted clinical and ‘omics research. As a result, labs have been challenged to innovate and identify new ways to increase operational efficiency and productivity to “do more” with less time, money and samples.

Shimadzu UltraFast Mass Spectrometry (UFMS) provides high-sensitivity performance and greater excellence in data quality, enabling dramatic improvements in laboratory throughput for an ever-widening range of analytical applications. Join us and learn how your lab can benefit from UFMS.

Learning Objectives:

• Learn how to increase throughput and data quality while reducing costs using UltraFast Mass Spectrometry.
• Understand how to perform large scale plasma/serum proteomic studies using sub-microliter volumes of sample.
• Recognize tactics being used by successful laboratories to thrive in a dynamic healthcare landscape.
• Examine the value of your mass spectrometer as a productivity tool.